Newly emergent acquired EGFR exon 18 G724S mutation after resistance of a T790M specific EGFR inhibitor osimertinib in non-small-cell lung cancer: a case report

Newly emergent acquired EGFR exon 18 G724S mutation after resistance of a T790M specific EGFR inhibitor osimertinib in non-small-cell lung cancer: a case report

Yan Zhang,1 Bixiu He,2 Dongbo Zhou,2 Min Li,1 Chengping Hu1 1Department of Respiratory Medicine, Xiangya Hospital (Key Cite of National Clinical Research Center for Respiratory Disease), Central South University, Changsha, Hunan, P.R. China; 2Department of Gerontology, Xiangya Hospital, Central Sou...

Full description

Bibliographic Details
Main Authors: Zhang Y, He B, Zhou D, Li M, Hu C
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:OncoTargets and Therapy
Subjects:
NSCLC
EGFR
AZD9291
T790M
G724S
resistance
Online Access:https://www.dovepress.com/newly-emergent-acquired-egfr-exon-18-g724s-mutation-after-resistance-o-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/newly-emergent-acquired-egfr-exon-18-g724s-mutation-after-resistance-o-peer-reviewed-article-OTT

Similar Items